FERRARI, Federica
 Distribuzione geografica
Continente #
NA - Nord America 1.396
EU - Europa 364
AS - Asia 265
SA - Sud America 11
Totale 2.036
Nazione #
US - Stati Uniti d'America 1.391
IT - Italia 161
CN - Cina 111
SG - Singapore 79
TR - Turchia 43
DE - Germania 41
GB - Regno Unito 40
UA - Ucraina 31
FI - Finlandia 28
SE - Svezia 19
ID - Indonesia 18
BE - Belgio 13
PL - Polonia 13
BR - Brasile 6
RU - Federazione Russa 6
AT - Austria 4
CA - Canada 4
PE - Perù 4
IN - India 3
VN - Vietnam 3
FR - Francia 2
HK - Hong Kong 2
IR - Iran 2
JP - Giappone 2
NL - Olanda 2
CL - Cile 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
ES - Italia 1
LT - Lituania 1
MX - Messico 1
TW - Taiwan 1
UZ - Uzbekistan 1
Totale 2.036
Città #
Fairfield 208
Woodbridge 140
Ann Arbor 119
Ashburn 116
Seattle 95
Ferrara 80
Houston 78
Singapore 72
Cambridge 67
Santa Clara 67
Wilmington 64
Chandler 63
Jacksonville 45
Izmir 43
Dearborn 42
New York 24
Shanghai 24
Princeton 23
Helsinki 21
Los Angeles 21
Beijing 20
Jakarta 18
Nanjing 17
Brussels 13
Warsaw 13
Boardman 11
Milan 10
Addison 9
Falkenstein 9
San Diego 9
London 8
Nanchang 7
Rimini 6
Falls Church 5
Padova 5
Cagliari 4
Des Moines 4
Guangzhou 4
Jinan 4
Leawood 4
Lima 4
Munich 4
Shenyang 4
Toronto 4
Augusta 3
Bari 3
Dong Ket 3
Ferrara di Monte Baldo 3
Grassano 3
Jiaxing 3
Kunming 3
Norwalk 3
San Mateo 3
Tianjin 3
Auburn Hills 2
Bologna 2
Bremen 2
Changsha 2
Council Bluffs 2
Gattico 2
Hong Kong 2
Innsbruck 2
Islington 2
Juiz De Fora 2
Leicester 2
Molinella 2
Mountain View 2
Prescot 2
Redwood City 2
Rome 2
San Giovanni Lupatoto 2
Somma Vesuviana 2
Tappahannock 2
Tokyo 2
Torino 2
Aberdeen 1
Amsterdam 1
Anyang 1
Ardabil 1
Baotou 1
Barnaul 1
Belo Horizonte 1
Boa Viagem 1
Bonn 1
Brno 1
Buffalo 1
Castellana Grotte 1
Catania 1
Chicago 1
Düsseldorf 1
Espoo 1
Fossò 1
Frankfurt am Main 1
Haikou 1
Hebei 1
Hefei 1
Imperatriz 1
Krasnodar 1
Linyi 1
Lviv 1
Totale 1.705
Nome #
Structure activity studies of nociceptin/orphanin FQ(1–13)-NH2 derivatives modified in position 5 147
A staged screening of registered drugs highlights remyelinating drug candidates for clinical trials 139
Pharmacological studies on the NOP and opioid receptor agonist PWT2-[Dmt(1)]N/OFQ(1-13) 135
Structure-and conformation-Activity studies of nociceptin/orphanin FQ receptor dimeric ligands 134
In vitro pharmacological characterization of a novel unbiased NOP receptor-selective nonpeptide agonist AT-403 124
Pharmacological characterization of tachykinin tetrabranched derivatives 121
Biased Agonism at Nociceptin/Orphanin FQ Receptors: A Structure Activity Study on N/OFQ(1-13)-NH2 112
In vitro functional characterization of novel nociceptin/orphanin FQ receptor agonists in recombinant and native preparations 111
Peptide welding technology – A simple strategy for generating innovative ligands for G protein coupled receptors 106
null 105
Tetrabranched Hetero-Conjugated Peptides as Bifunctional Agonists of the NOP and Mu Opioid Receptors 102
(2S)-N-2-methoxy-2-phenylethyl-6,7-benzomorphan compound (2S-LP2): Discovery of a biased mu/delta opioid receptor agonist 93
Pharmacological profile of the neuropeptide S receptor: Dynamic mass redistribution studies 92
Cyclopeptide Dmt-[D-Lys-p-CF3-Phe-Phe-Asp]NH2, a novel G protein-biased agonist of the mu opioid receptor 86
Modulation of Drosophila suzukii type 1 tyramine receptor (DsTAR1) by monoterpenes: a potential new target for next generation biopesticides 81
Synthesis and Pharmacological Evaluation of Hybrids Targeting Opioid and Neurokinin Receptors 74
Prevenzione e Cura della carenza di vitamina E nei pazienti colestatici: il tocofersolano (Vedrop) per via orale 66
Pharmacological profile of nociceptin/orphanin FQ receptor – characterization of novel peptide and non peptide ligands 62
Structure-Activity Relationship Studies on Oxazolo[3,4- a]pyrazine Derivatives Leading to the Discovery of a Novel Neuropeptide S Receptor Antagonist with Potent in Vivo Activity 59
Pharmacological characterization of cebranopadol a novel analgesic acting as mixed nociceptin/orphanin FQ and opioid receptor agonist 53
Novel Mixed NOP/Opioid Receptor Peptide Agonists 50
In vitro and in vivo activity of cyclopeptide Dmt-c[D-Lys-Phe-Asp]NH2, a mu opioid receptor agonist biased toward β-arrestin 45
Totale 2.097
Categoria #
all - tutte 12.783
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.783


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020149 0 0 0 0 0 0 0 42 53 29 12 13
2020/2021344 17 13 23 21 12 39 58 37 18 35 45 26
2021/2022200 13 9 3 20 5 20 18 14 10 23 10 55
2022/2023191 26 17 13 30 11 16 14 28 16 1 13 6
2023/2024181 14 20 4 8 10 35 11 24 4 9 1 41
2024/2025311 21 21 76 25 51 99 7 11 0 0 0 0
Totale 2.097